I dont believe for one moment that whats going on here is an honest investigation of whether these products should be compounded. Scott Brunner of the Alliance for Pharmacy Compounding said the coming meeting will be the start of a protracted process. Even if the panel votes to make the peptides available, and the FDA agrees, the agency will still have to draft and publish rules on the change, he noted
For gut healing specifically, taking it orally or intraperitoneally puts the peptide in direct contact with the gut lining
- Lichtheim's disease or syndrome - D51.0 - Myasthenia - G70.9 - syndrome - in - pernicious anemia - D51.0 - Myelopathy (spinal cord) - G95.9 - pernicious anemia - D51.0 - Neuropathy, neuropathic - G62.9 - vitamin B12 - E53.8 - with anemia (pernicious) - D51.0 - Polyneuropathy (peripheral) - G62.9 - vitamin B12 deficiency - E53.8 - with anemia (pernicious) - D51.0 - Runeberg's disease - D51.0 - Syndrome - See Also: Disease
In vitro studies using normal human epidermal keratinocytes revealed that treatment with glutathione amino acid precursors significantly increased both GSH and glutathione disulfide levels, leading to an improved GSH/glutathione disulfide ratio, which is a key indicator of cellular redox balance
Genuine lasting damage from topical copper peptides is rare
